Cinven secures Italian nod to sell minority stake in Synlab to Labcorp

Reuters11-20 17:18

ROME, Nov 20 (Reuters) - Private equity firm Cinven secured a conditional approval from Italian authorities over its plan to sell a 15% stake in diagnostic service provider Synlab to laboratory operator Labcorp , a government document sent to parliament showed.

Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.

Italy's cabinet authorised the transaction on Nov. 12 with some unspecified conditions, according to the document.

Announced in September, the deal is worth some 150 million euros ($158.48 million).

($1 = 0.9465 euros)

(Reporting by Giuseppe Fonte, Editing by Louise Heavens)

((giuseppe.fonte@thomsonreuters.com; +390680307711;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment